Project Grant K23AI175660
Award Date
7/26/24
Completion Date
6/30/27
Dollars Obligated
$162K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Burlington, VT 05405, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the regulation of the Vibrio cholerae MSHA pilus and its role in the bacterium's transition between environmental colonization and host infection. The $822,209 award, effective July 2, 2024 through June 30, 2027, aims to elucidate the mechanisms by which the fatty acid metabolism regulator...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $752,745 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Massachusetts Medical School (UMass Medical) to conduct research on the dynamics and evolution of HIV Gag and GagPol processing. The research aims to use molecular dynamics simulations, single-molecule FRET imaging, and cryo-electron tomography to probe the structural and dynamic features of Gag and GagPol...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $226,641 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Colorado-Denver. The award, effective from December 5, 2024 to November 30, 2026, supports research to examine how the intestinal microbiome and the pattern recognition receptor NOD2 expressed in intestinal epithelial cells (IECs) impact Coxsackievirus B3 (CVB3) pathogenesis. The research aims to determine...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $908,790 to Tufts University School of Medicine to study the mechanisms by which the bacteriophage ICP3 overcomes the phage defense systems of Vibrio cholerae, the bacteria that causes cholera. The research aims to delete each of ICP3's accessory genes and identify the corresponding host phage defense genes in V....
This $188,980 federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to elucidate the role of intestinal M cells in Rotavirus (RV) enteric infection, systemic dissemination, and pathogenesis. The research will determine the extraintestinal tissues and cell types targeted by RV following oral inoculation, and utilize Villin-Cre TNFRSF11AFlox/Flox mice lacking intestinal...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $657,506 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Ohio State University. The award, effective August 6, 2024 through July 31, 2025, will fund research to develop a novel subunit vaccine for pertussis that elicits mucosal immunity and prevents nasal colonization by the Bordetella pertussis pathogen. Key activities include testing an intranasal booster vaccine containing...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) in the amount of $609,924 will support research at the University of Rochester to investigate the mechanisms used by the pathogen Vibrio cholerae, which causes the severe diarrheal disease cholera, to coordinate virulence and physiological traits necessary for its dual aquatic and human pathogenic lifestyles. The research aims to identify and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $104,984 to Pennsylvania State University to conduct research on how the Merkel Cell Polyomavirus (MCPyV) induces the nucleolar stress response (NSR) in infected cells. The goal is to determine the mechanisms by which MCPyV's large tumor antigen (LT) inhibits ribosomal biogenesis, leading to activation of the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $125,160 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Ohio State University. The funding supports a research project to characterize the structure and function of a novel bacterial immune system. Key objectives include using cryo-electron microscopy to define the assembly and mechanisms of the immune system components, and developing biochemical and cellular assays to...
This $728,244 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to investigate the mechanisms of virulence factors and injectisome assembly in bacterial pathogens like Salmonella, Shigella, Vibrio, Pseudomonas, Yersinia, and Chlamydia. The research aims to provide fundamental knowledge about injectisome function and gene regulatory systems, which is crucial for...